Participants need to register for the conference before submitting an abstract.

  1. Create an account in the conference management portal (portal will open in November).
  2. Register and pay the fees.
  3. Submit an abstract.
Important Dates
November 2021 Call for Abstracts opens
February 18, 2022 Abstract Submission Deadline
March 31, 2022 Notification of Abstract Acceptance
April 15, 2022 Deadline for Presenting Authors to Accept Invitation to Present
Abstract Format & Content
  • Abstracts must be written in English.
  • Length of abstract body: max. 2000 characters (with spaces)
  • Title: max. 200 characters (with spaces). Sentence case obligatory.
  • The following abstract subheadings must be used: Introduction, Methods, Results, Conclusions
  • The abstract must be submitted in final form. It will be published as it was submitted. The body of the abstract may be formatted by the program manager in order to follow the guidelines.
  • Abstracts should be concise and informative and include at least preliminary data. Those stating that results will be presented or discussed may be subject to rejection.
  • Non-standard abbreviations should be placed in parentheses after the full term the first time they appear.
  • The use of trade names and company identification is not permitted.
  • Submissions not conforming to the established guidelines may not be reviewed.
Abstracts can be submitted in the following categories
Genetics & genomics 
Proteomics
Biomarkers & molecular signatures
Pathology & disease classification
Biobanking
Predisposition & risk factors
Stem cells & precursor lesions
Cell biology
In vitro & in vivo models
Tumour microenvironment
Immunology & immunotherapy
Novel therapeutics
Mechanisms of metastasis
Chemoresistance & recurrence
Surgical outcomes
Survivorship & psychosocial issues
Other